OTC Squawkotc·squawk
⏎
Log inSign up
OTC Squawk
Log inSign up
FeedDiscoverTickersNotificationsProfileSign in to squawk
Back to feed
@jjtrades2
JJ Trades2@jjtrades2·about 1 month ago

$BFCH

As of late May 2026, BFCH is in a wide sideways-to-bullish base near multi-month lows, following earlier 2026 volatility:

Key Patterns:

Double Bottom (early-to-mid May) around $0.0006–$0.0007 area, with a recent bounce confirming short-term support.

Bullish Divergence on volume/price in recent sessions.

Trading above short-term moving averages but well below the 2026 high ($0.0024).

Possible bull pennant or tight consolidation forming if it holds $0.0007–$0.0008.

Support Levels: $0.0007 (recent pivot), $0.0006

Resistance Levels: $0.0009 – $0.0010, then $0.0015–$0.0020

Potential Trade Setups (Speculative – High Risk):

Bullish Continuation: Break and hold above $0.0009 on strong volume → targets $0.0012–$0.0015 (measured move from double bottom).

Dip Buy: At $0.0007 support with tight stop below $0.0006.

Bearish Breakdown: Loss of $0.0007 could retest $0.0004–$0.0005.

Bias: Neutral-to-cautiously bullish in the very short term due to the bounce and acquisition news, but overall trend remains choppy with low liquidity risks. News flow around the wellness pivot and potential Reg A could act as catalysts.

0Tipped
BullishBearish
41

Reply

Join the conversation.

Sign up to reply, follow traders, and track your tickers.

Sign upLog in

Replies

4
  • @jjtrades2
    JJ Trades2@jjtrades2·about 1 month ago
    Transaction Overview Acquired Entity: VerdaGenix, LLC (dba Ancient Extracts USA), a direct-to-consumer (DTC) wellness platform. Closing Date: May 19, 2026 (announced same day). Structure: 100% acquisition — Ancient Extracts USA is now a wholly owned subsidiary of BFCH (operating as UNLOCKD Inc.). Purchase Price: Approximately $490,000 (equity-based transaction). This included conversion of ~$225,000 in existing third-party debt into BFCH equity, plus additional shares and potential inventory adjustments. Timeline: Binding LOI executed April 23, 2026; closed roughly 4 weeks later.
    Reply0Report
  • @jjtrades2
    JJ Trades2@jjtrades2·about 1 month ago
    What BFCH Acquired Ancient Extracts USA brings an operating, revenue-generating wellness business with the following assets: Diversified catalog of 20+ commercialized SKUs (wellness products). Key product categories: Mushroom coffee/alternatives, ceremonial-grade matcha, shilajit, adaptogens, botanical performance blends, and functional mushroom extracts. Fully integrated DTC infrastructure: E-commerce platform, digital marketing systems (TikTok, Amazon, Meta), customer acquisition channels, fulfillment, and inventory. Proprietary formulations, intellectual property, trade secrets, supplier relationships, and existing commercial operations. This marks a significant pivot for BFCH from its original crypto/blockchain mining roots toward a consumer wellness and functional nutrition platform under the UNLOCKD brand.
    Reply0Report
  • @jjtrades2
    JJ Trades2@jjtrades2·about 1 month ago
    Strategic Rationale & Impact Positive Aspects: De-risking & Pivot: Adds immediate revenue streams and operational infrastructure, reducing reliance on volatile crypto markets. Management describes it as accelerating the transition into a "scalable consumer wellness operating platform." Growth Platform: Provides a base for further brand acquisitions and expansions (e.g., mentioned alongside potential EVERMIND™ integration in prior updates). Existing DTC systems and retail placements (recent posts note new high-end retail channels) offer quick scaling potential. Timing & Leadership: Closed alongside the appointment of veteran operator John P. Gorst as CEO (May 14, 2026), signaling intent to professionalize and commercialize aggressively. Low Cost Entry: At ~$490k for a post-revenue business with 20+ SKUs and infrastructure, the valuation appears modest for a public company platform play.
    Reply0Report
  • @jjtrades2
    JJ Trades2@jjtrades2·about 1 month ago
    Bottom Line The Ancient Extracts USA acquisition is a material positive step for BFCH/UNLOCKD. It delivers tangible operations, products, and infrastructure at a reasonable price, supporting the company's stated strategy of building a roll-up platform in wellness. Success now depends on: Revenue growth and commercialization execution under new CEO Gorst. Securing additional growth capital (management has indicated plans for this). Potential follow-on acquisitions. This is not financial advice. BFCH remains a high-risk OTC micro-cap with extreme volatility and liquidity issues. For deeper due diligence, review the company's OTC Markets filings, full press releases, and the Ancient Extracts site (ancientextracts.com).
    Reply0Report